Preparation of strong antidandruff shampoo using medicinal plant extracts: A clinical trial and chronic dandruff treatment

Jundishapur Journal of Natural Pharmaceutical Products

Volumn 10, Issue 4, 2015, Pages

  Sahraie Rad, Masoud ^a   Izadyari, Azadeh ^b   Rakizadeh, Saharnaz ^c   Sharifi Rad, Javad ^d  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c UNIVERSITY OF TEHRAN   (Iran)

^d ZABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Dandruff; Malassezia; Medicinal plant; Pirocton olamine; Plant extracts

Indexed keywords

ALKALOID; DERMATOLOGICAL AGENT; GLYCOSIDE; MATRICARIA CHAMOMILLA EXTRACT; METHANOL; PEPPERMINT; PHENOL; PLANT EXTRACT; POMEGRANATE EXTRACT; PYROGLUTAMIC ACID; RESIN; ROSMARINUS OFFICINALIS EXTRACT; SALVIA OFFICINALIS EXTRACT; SAPONIN; SHAMPOO; STEROID; TANNIN; URTICA DIOICA EXTRACT;

ADOLESCENT; ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL ARTICLE; DANDRUFF; FEMALE; HUMAN; MALE; MATRICARIA CHAMOMILLA; MEDICINAL PLANT; MENTHA PIPERITA; MIDDLE AGED; POMEGRANATE; PRURITUS; ROSEMARY; SALVIA OFFICINALIS; SATISFACTION; URTICA DIOICA; YOUNG ADULT;

EID: 84949843619     PISSN: 17357780     EISSN: 22287876     Source Type: Journal    
DOI: 10.17795/jjnpp-21517     Document Type: Article

References (53)

1. Chhavi S, Sushma D, Mahammad A. Potential of herbals as antidandruff agents. IRJP. 2011;2(3):16-8.
2. Ravichandran G, Bharadwaj VS, Kolhapure SA. Evaluation of the clinical efficacy and safety of "Anti-Dandruff Shampoo" in the treatment of dandruff. The Antiseptic. 2004;201(1):5-8.
3. Cornah J, Wallace J. Polydioxanone (PDS): a new material for internal suspension and fixation. Br J Oral Maxillofac Surg. 1988;26(3):250-4. [PubMed: 3134937]
4. Adamski Z, Deja M. The treatment of dandruff of the scalp. Aesthet Dermatol. 2006;2:49-56.
5. Voravuthikunchai SP, Sririrak T, Limsuwan S, Supawita T, Iida T, Honda T. Inhibitory effects of active compounds from Punica granatum pericarp on verocytotoxin production by enterohemorrhagic Escherichia coli O157: H7. Journal of health science. 2005;51(5):590-6.
6. Vasconcelos LC, Sampaio MC, Sampaio FC, Higino JS. Use of Punica granatum as an antifungal agent against candidosis associated with denture stomatitis. Mycoses. 2003;46(5-6):192-6. [PubMed: 12801361]
7. British Herbal Pharmacopoeia. The Stationery Office on behalf of the Medicines and Healthcare products; 2009. pp. 7324-31.
8. Munne-Bosch S, Alegre L. Subcellular compartmentation of the diterpene carnosic acid and its derivatives in the leaves of rosemary. Plant Physiol. 2001;125(2):1094-102. [PubMed: 11161064]
9. Van WB, Wink M. Medicinal Plants of the World: An illustrated scientific guide to important medicinal plants and their uses. Portland Oregon: Timber Press; 2004.
10. AlShuwayeb MH, Al-Khatib AJ. Molecular and chemical therapeutic features of Urtica species. Eur. Sci. J. 2013;9(24)
11. Dorman HJ, Kosar M, Baser KH, Hiltunen R. Phenolic profile and antioxidant evaluation of Mentha x piperita L. (peppermint) extracts. Nat Prod Commun. 2009;4(4):535-42. [PubMed: 19476001]
12. Krzyzanowska J, Janda B, Pecio L, Stochmal A, Oleszek W, Czubacka A, et al. Determination of polyphenols in Mentha longifolia and M. piperita field-grown and in vitro plant samples using UPLC-TQ-MS. J AOAC Int. 2011;94(1):43-50. [PubMed: 21391480]
13. Akbarpour V, Hemmati K, Sharifani M. Physical and chemical properties of pomegranate (Punica granatum L.) fruit in maturation stage. T AM-Eur. J. AGR ENVIRON SCI. 2009;6(4):411-6.
14. Moslemi M, Zahravi M, Khaniki GB. Genetic diversity and population genetic structure of pomegranate (Punica granatum L.) in Iran using AFLP markers. SCI HORTIC-AMSTERDAM. 2010;126(4):441-7.
15. Debjit B, Harish G, Kumar BP, Duraivel S, Aravind G, Sampath Kumar KP. Medicinal Uses of Punica granatum and Its Health Benefits. J Pharmacogn and Phytochem. 2003;1(5):28-35.
16. Lansky EP, Newman RA. Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer. J Ethnopharmacol. 2007;109(2):177-206. doi: 10.1016/j. jep.2006.09.006. [PubMed: 17157465]
17. Kim ND, Mehta R, Yu W, Neeman I, Livney T, Amichay A, et al. Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer. Breast Cancer Res Treat. 2002;71(3):203-17. [PubMed: 12002340]
18. Rad JS, Alfatemi SM, Rad MS, Iriti M. In-vitro antioxidant and antibacterial activities of Xanthium strumarium L. extracts on methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Anc Sci Life. 2013;33(2):109-13. doi: 10.4103/0257-7941.139050. [PubMed: 25284944]
19. Alfatemi SMH, Rad JS, Rad MS, Mohsenzadeh S, da Silva JAT. Chemical composition, antioxidant activity and in vitro antibacterial activity of Achillea wilhelmsii C. Koch essential oil on methicillin-susceptible and methicillin-resistant Staphylococcus aureus spp. 3 Biotech. 2015;5(1):39-44.
20. Rad JS, Alfatemi MH, Rad MS, Sen DJ. Phytochemical and Antimicrobial Evaluation of the Essential Oils and Antioxidant Activity of Aqueous Extracts from Flower and Stem of Sinapis arvensis L. Am. J. Adv. Drug Delivery. 2013;1(1):01-10.
21. Sharifi Rad J, Hoseini Alfatemi SM, Sharifi Rad M, Iriti M. Free Radical Scavenging and Antioxidant Activities of Different Parts of Nitraria schoberi L. J. Biol. Act. Prod. Nat. 2014;4(1):44-51.
22. Rad JS, Alfatemi SMH, Rad MS. In vitro assessment of antibacterial activity of Salicornia herbacea L. seed extracts against multidrug resistant gram-positive and gram-negative bacteria. Int J Biosci. 2014;4(6):217-22.
23. Rahimi HR, Arastoo M, Ostad SN. A Comprehensive Review of Punica granatum (Pomegranate) Properties in Toxicological, Pharmacological, Cellular and Molecular Biology Researches. Iran J Pharm Res. 2012;11(2):385-400. [PubMed: 24250463]
24. Khan JA, Hanee S. Antibacterial Properties of Punica dranatum Peels. Int J App Biol Pharma Technol. 2011;2(3).
25. Akhlaghi M, Bandy B. Mechanisms of flavonoid protection against myocardial ischemia-reperfusion injury. J Mol Cell Cardiol. 2009;46(3):309-17. doi: 10.1016/j.yjmcc.2008.12.003. [PubMed: 19133271]
26. Rahimi HR, Arastoo M, Shiri M. Punica granatum is more effective to prevent gastric disorders induced by Helicobacter pylori or any other stimulator in humans. Asian J. Plant Sci. 2011.
27. European Pharmacopoeia 2S.
28. Williams CE. Trease and evans pharmacognosy. Oxford: Saunders Elsevier Edinburg; 2009.
29. Juhas S, Bukovska A, Cikos S, Czikkova S, Fabian D, Koppel J. Antiinflammatory effects of Rosmarinus officinalis essential oil in mice. Acta Veterinaria Brno. 2009;78(1):121-7.
30. Derwich E, Benziane Z, Chabir R. Aromatic and medicinal plants of morocco: chemical composition of essential oils of Rosmarinus officinalis and Juniperus Phoenicea. Int J App Biol Pharma Technol. 2011.
31. Gupta V, Mittal P, Bansal P, Khokra SL, Kaushik D. Pharmacological Potential of Matricaria recutita-A Review. Int J Pharma Sci Drug Res. 2010;2(1):12-6.
32. Dewick PM. The biosynthesis of C5-C25 terpenoid compounds. Nat Prod Rep. 2002;19(2):181-222. [PubMed: 12013278]
33. Baylac S, Racine P. Inhibition of 5-lipoxygenase by essential oils and other natural fragrant extracts. International Journal of Aromatherapy. 2003;13(2):138-42.
34. Pino JA, Marbot R, Agiiero J, Fuentes V. Essential oil of chamomile Chamomilla recutita (L.) Rausch. from Cuba. J Essent Oil-Bear Plants. 2000;3:1-3.
35. Saller R. [Peppermint (Mentha x piperita), medicinal plant of the year 2004]. Forsch Komplementarmed Klass Naturheilkd. 2004;11(1):6-7. doi: 10.1159/000077189. [PubMed: 15004441]
36. Rita P, Animesh DK. An updated overview on peppermint (Mentha piperita L.). Int. Res. J. Pharm. 2011;8(2):1-10.
37. Shah PP, Mello PMD. A review of medicinal uses and pharmacological effects of Mentha piperita. Indian J. Nat. Prod. Resour. 2004;3:214-21.
38. Moghtader M. In vitro antifungal effects of the essential oil of Mentha piperita L. and its comparison with synthetic menthol on Aspergillus niger. Afr. J. Plant Sci. 2013;7(11):521-7.
39. Badiee P, Nasirzadeh AR, Motaffaf M. Comparison of Salvia officinalis L. essential oil and antifungal agents against candida species. J. Pharm. Technol. Drug Res. 2012;1(1):7.
40. Baricevc D, Bartol T. The biological/pharmacological activity of the Salvia genus V., pharmacology. In: Kintzios SE, editor. SAGE-The Genus Salvia. Amsterdam: Harwood Academic; 2000. pp. 143-84.
41. Delamare APL, Moschen-Pistorello IT, Artico L, Atti-Serafini L, Echeverrigaray S. Antibacterial activity of the essential oils of Salvia officinalis L. and Salvia triloba L. cultivated in South Brazil. FOOD CHEM. 2007;100(2):603-8.
42. Liu RH. Potential synergy of phytochemicals in cancer prevention: mechanism of action. J Nutr. 2004;134(12 Suppl):3479S-85S. [PubMed: 15570057]
43. Ferguson LR, Philpott M. Nutrition and mutagenesis. Annu Rev Nutr. 2008;28:313-29. doi: 10.1146/annurev.nutr.28.061807.155449. [PubMed: 18399774]
44. Baricevic D, Sosa S, Della Loggia R, Tubaro A, Simonovska B, Krasna A, et al. Topical anti-inflammatory activity of Salvia officinalis L. leaves: the relevance of ursolic acid. J Ethnopharmacol. 2001;75(2-3):125-32. [PubMed: 11297842]
45. Zupko I, Hohmann J, Redei D, Falkay G, Janicsak G, Mathe I. Antioxidant activity of leaves of Salvia species in enzyme-dependent and enzyme-independent systems of lipid peroxidation and their phenolic constituents. Planta Med. 2001;67(4):366-8. [PubMed: 11458459]
46. Schneider I, Bucar F. Lipoxygenase inhibitors from natural plant sources. Part 1: Medicinal plants with inhibitory activity on arachidonate 5-lipoxygenase and 5-lipoxygenase[sol ]cyclooxygenase. Phytother Res. 2005;19(2):81-102. doi: 10.1002/ptr.1603. [PubMed: 15852496]
47. Kim HP, Son KH, Chang HW, Kang SS. Anti-inflammatory plant flavonoids and cellular action mechanisms. J Pharmacol Sci. 2004;96(3):229-45. [PubMed: 15539763]
48. Tekeli Y, Zengin G, Aktumsek A, Sezgin M, Torlak E. Antibacterial activities of extracts from twelve Centaurea species from Turkey. Archives of Biological Sciences. 2011;63(3):685-90.
49. WHO. Quality Control Methods for Medicinal Plant Materials, 1998 2011.
50. European Medicines Agency. ICH E8 General Considerations for Clinical Trials-March. 1998. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002877.pdf.
51. ICH S7A Safety Pharmacology Studies for Human Pharmaceuticals. 2001.
52. Rice M, Susan C. World Medical Association Declaration of Helsinki Clinical Research in Occupational Therapy. Research Design Methodology.:271-9.
53. Journal of American Medical Association. World Medical Association Declaration OF Helsinki Ethical Principles for Medical Research Involving Human Subjects. Available from: http://jama.jamanetwork.com/.